The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BIOL | -98.89% | N/A | N/A | -100% |
| S&P | +16.23% | +94.45% | +14.22% | +1,494% |
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
There's a lot happening in the new week.
Hold still, I need to stick this laser in your mouth.
| Q3 2024 | YOY Change | |
|---|---|---|
| Revenue | $10.85M | 0.0% |
| Gross Profit | $4.38M | 0.0% |
| Gross Margin | 40.39% | 0.0% |
| Market Cap | $2.47M | 0.0% |
| Market Cap / Employee | $0.02M | 0.0% |
| Employees | 157 | 0.0% |
| Net Income | -$1.43M | 0.0% |
| EBITDA | -$0.05M | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2024 | YOY Change | |
|---|---|---|
| Net Cash | $3.44M | 0.0% |
| Accounts Receivable | $3.53M | 0.0% |
| Inventory | 9.9 | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.56M | 0.0% |
| Short Term Debt | $16.90M | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -48.61% | 0.0% |
| Return On Invested Capital | -160.44% | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4.51M | 0.0% |
| Operating Free Cash Flow | -$4.47M | 0.0% |
| Metric | Q2 2024 | Q3 2024 | YoY Change | ||
|---|---|---|---|---|---|
| Price to Book | -1.72 | -0.47 | - | ||
| Price to Sales | 0.07 | 0.07 | 0.07 | 0.05 | - |
| Price to Tangible Book Value | -0.68 | -0.30 | - | ||
| Enterprise Value to EBITDA | -3.34 | -3.79 | -5.80 | -328.86 | - |
| Return on Equity | -888.9% | -683.4% | -1675.2% | - | |
| Total Debt | $17.91M | $17.66M | $16.85M | $17.46M | - |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
